Issue: 2019 > July > case report

Large-vessel vasculitis associated with PEGylated granulocyte-colony stimulating factor

K. Yukawa, S. Mokuda, Y. Yoshida, S. Hirata, E. Sugiyama
AbstractFull textPDF


A 71-year-old female with advanced endometrial cancer was treated with pegfilgrastim. She developed a fever within seven days, and contrast-enhanced computed tomography scans repeated within three days revealed rapidly progressive thickening of the aortic wall. When clinicians administer PEGylated granulocyte-colony stimulating factor (G-CSF) to cancer patients, drug-associated vasculitis should be suspected. This report discusses the manifestation of G-CSF-associated large-vessel vasculitis (LVV).